• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

生活方式改变在非酒精性脂肪性肝病综合治疗中的作用

The Role of Life Style Modifications in Comprehensive Non-Alcoholic Fatty Liver Disease Treatment.

作者信息

Viveiros Kathleen

机构信息

Gastroenterology/Hepatology Department of Medicine Brigham and Women's Hospital Boston MA.

出版信息

Clin Liver Dis (Hoboken). 2021 Feb 1;17(1):11-14. doi: 10.1002/cld.1007. eCollection 2021 Jan.

DOI:10.1002/cld.1007
PMID:33552479
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7849295/
Abstract

Watch a video presentation of this article Watch an interview with the author.

摘要

观看本文的视频演示。观看对作者的采访。

相似文献

1
The Role of Life Style Modifications in Comprehensive Non-Alcoholic Fatty Liver Disease Treatment.生活方式改变在非酒精性脂肪性肝病综合治疗中的作用
Clin Liver Dis (Hoboken). 2021 Feb 1;17(1):11-14. doi: 10.1002/cld.1007. eCollection 2021 Jan.
2
Clinical presentation of alcoholic liver disease and non-alcoholic fatty liver disease: spectrum and diagnosis.酒精性肝病和非酒精性脂肪性肝病的临床表现：范围与诊断
Transl Gastroenterol Hepatol. 2020 Apr 5;5:19. doi: 10.21037/tgh.2019.10.02. eCollection 2020.
3
Dorothy Hodgkin Lecture 2012: non-alcoholic fatty liver disease, insulin resistance and ectopic fat: a new problem in diabetes management.2012 年多萝西·霍奇金讲座：非酒精性脂肪性肝病、胰岛素抵抗和异位脂肪：糖尿病管理中的新问题。
Diabet Med. 2012 Sep;29(9):1098-107. doi: 10.1111/j.1464-5491.2012.03732.x.
4
[Physical activity intervention for non-alcoholic fatty liver disease in children].[儿童非酒精性脂肪性肝病的体育活动干预]
Zhonghua Gan Zang Bing Za Zhi. 2020 Sep 20;28(9):794-798. doi: 10.3760/cma.j.cn501113-20190709-00239.
5
Lifestyle Modifications in Non-Alcoholic Fatty Liver Disease and Non- Alcoholic Steatohepatitis.非酒精性脂肪肝和非酒精性脂肪性肝炎的生活方式改变。
Curr Vasc Pharmacol. 2018;16(3):239-245. doi: 10.2174/1570161115666170621080835.
6
Non-alcoholic fatty liver disease and lifestyle modifications, focusing on physical activity.非酒精性脂肪性肝病与生活方式改变，重点关注体育活动。
Korean J Intern Med. 2018 Jan;33(1):64-74. doi: 10.3904/kjim.2017.343. Epub 2017 Dec 6.
7
[Interview with PD Dr. Anton Gillessen, Münster. Non-alcoholic fatty liver: change in the life style!].[对明斯特的安东·吉列森博士的采访。非酒精性脂肪肝：生活方式的改变！]
MMW Fortschr Med. 2015 Jan 19;157(1):69.
8
Nonalcoholic Steatohepatitis, Sarcopenia, and Liver Transplantation.非酒精性脂肪性肝炎、肌肉减少症与肝移植
Clin Liver Dis (Hoboken). 2021 Feb 1;17(1):2-5. doi: 10.1002/cld.1000. eCollection 2021 Jan.
9
Treatment of non-alcoholic fatty liver disease: can we already face the epidemic?非酒精性脂肪性肝病的治疗：我们能否应对这一流行病？
Acta Gastroenterol Belg. 2013 Jun;76(2):200-9.
10
[Diagnosis and therapeutic strategies for non-obese type of non-alcoholic fatty liver diseases].非肥胖型非酒精性脂肪性肝病的诊断与治疗策略
Zhonghua Gan Zang Bing Za Zhi. 2020 Mar 20;28(3):203-207. doi: 10.3760/cma.j.cn501113-20191226-00480.

引用本文的文献

1
Assessing Nonalcoholic Fatty Liver Disease in Type 2 Diabetes Patients at a Tertiary Hospital, Addis Ababa, Ethiopia.埃塞俄比亚亚的斯亚贝巴一家三级医院对2型糖尿病患者的非酒精性脂肪性肝病评估。
J Diabetes Res. 2025 Aug 23;2025:5555842. doi: 10.1155/jdr/5555842. eCollection 2025.
2
Efficacy and safety of the FGF19 analog aldafermin for the treatment of nonalcoholic steatohepatitis: a GRADE assessed systematic review and meta-analysis.FGF19类似物aldafermin治疗非酒精性脂肪性肝炎的疗效与安全性：一项GRADE评估的系统评价和荟萃分析
Ann Med Surg (Lond). 2024 Oct 16;86(12):7072-7081. doi: 10.1097/MS9.0000000000002649. eCollection 2024 Dec.
3
Systemic impacts of metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) on heart, muscle, and kidney related diseases.代谢功能障碍相关脂肪性肝病（MASLD）和代谢功能障碍相关脂肪性肝炎（MASH）对心脏、肌肉和肾脏相关疾病的全身影响。
Front Cell Dev Biol. 2024 Jul 16;12:1433857. doi: 10.3389/fcell.2024.1433857. eCollection 2024.
4
The Evolution in Non-Alcoholic Fatty Liver Disease Patients' Profile and the Associated Sustainable Challenges: A Multidisciplinary Perspective.非酒精性脂肪性肝病患者特征的演变及相关可持续性挑战：多学科视角。
Nutrients. 2024 May 23;16(11):1584. doi: 10.3390/nu16111584.
5
Phosphorylation: new star of pathogenesis and treatment in steatotic liver disease.磷酸化：脂肪性肝病发病机制和治疗的新靶点。
Lipids Health Dis. 2024 Feb 17;23(1):50. doi: 10.1186/s12944-024-02037-9.
6
Update on Clinical Trials for Nonalcoholic Steatohepatitis.非酒精性脂肪性肝炎临床试验的最新进展
Gastroenterol Hepatol (N Y). 2023 Jul;19(7):371-381.
7
Differential Effects of COVID-19 Hospitalization on the Trajectory of Liver Disease Progression.新冠病毒疾病住院治疗对肝脏疾病进展轨迹的差异影响。
Gastro Hep Adv. 2023;2(4):480-486. doi: 10.1016/j.gastha.2023.01.020. Epub 2023 Feb 12.
8
Comparative Transcriptome Analysis Reveals That Exendin-4 Improves Steatosis in HepG2 Cells by Modulating Signaling Pathways Related to Lipid Metabolism.比较转录组分析表明，艾塞那肽-4通过调节与脂质代谢相关的信号通路改善HepG2细胞中的脂肪变性。
Biomedicines. 2022 Apr 28;10(5):1020. doi: 10.3390/biomedicines10051020.
9
Nonalcoholic Fatty Liver Disease: Could It Be the Next Medical Tsunami?非酒精性脂肪性肝病：会成为下一场医学海啸吗？
Cureus. 2022 Apr 4;14(4):e23806. doi: 10.7759/cureus.23806. eCollection 2022 Apr.
10
Anthocyanins: Traditional Uses, Structural and Functional Variations, Approaches to Increase Yields and Products' Quality, Hepatoprotection, Liver Longevity, and Commercial Products.花色苷：传统用途、结构和功能变化、提高产量和产品质量的方法、肝保护、肝脏长寿和商业产品。
Int J Mol Sci. 2022 Feb 15;23(4):2149. doi: 10.3390/ijms23042149.

本文引用的文献

1
Standardisation of diet and exercise in clinical trials of NAFLD-NASH: Recommendations from the Liver Forum.非酒精性脂肪性肝病-非酒精性脂肪性肝炎临床试验中饮食和运动的标准化：肝脏论坛的建议。
J Hepatol. 2020 Sep;73(3):680-693. doi: 10.1016/j.jhep.2020.04.030. Epub 2020 Apr 27.
2
Beneficial effects of the ketogenic diet on nonalcoholic fatty liver disease: A comprehensive review of the literature.生酮饮食对非酒精性脂肪性肝病的有益作用：文献综述。
Obes Rev. 2020 Aug;21(8):e13024. doi: 10.1111/obr.13024. Epub 2020 Mar 24.
3
Lifestyle modification in NAFLD/NASH: Facts and figures.非酒精性脂肪性肝病/非酒精性脂肪性肝炎中的生活方式改变：事实与数据。
JHEP Rep. 2019 Nov 5;1(6):468-479. doi: 10.1016/j.jhepr.2019.10.008. eCollection 2019 Dec.
4
Smoking and the Risk of Non-Alcoholic Fatty Liver Disease: A Cohort Study.吸烟与非酒精性脂肪性肝病风险：队列研究。
Am J Gastroenterol. 2019 Mar;114(3):453-463. doi: 10.1038/s41395-018-0283-5.
5
Does stress influence sleep patterns, food intake, weight gain, abdominal obesity and weight loss interventions and vice versa?压力会影响睡眠模式、食物摄入、体重增加、腹部肥胖和减肥干预措施吗？反之亦然？
Obes Rev. 2018 Jan;19(1):81-97. doi: 10.1111/obr.12603. Epub 2017 Aug 28.
6
Efficacy of dietary and physical activity intervention in non-alcoholic fatty liver disease: a systematic review.饮食和体育活动干预对非酒精性脂肪性肝病的疗效：一项系统评价
BMJ Open Gastroenterol. 2017 Jun 1;4(1):e000139. doi: 10.1136/bmjgast-2017-000139. eCollection 2017.
7
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases.非酒精性脂肪性肝病的诊断与管理：美国肝病研究协会的实践指南
Hepatology. 2018 Jan;67(1):328-357. doi: 10.1002/hep.29367. Epub 2017 Sep 29.
8
Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis.通过生活方式改变减轻体重可显著改善非酒精性脂肪性肝炎的特征。
Gastroenterology. 2015 Aug;149(2):367-78.e5; quiz e14-5. doi: 10.1053/j.gastro.2015.04.005. Epub 2015 Apr 10.
9
Association of coffee and caffeine consumption with fatty liver disease, nonalcoholic steatohepatitis, and degree of hepatic fibrosis.咖啡和咖啡因摄入与脂肪性肝病、非酒精性脂肪性肝炎及肝纤维化程度的相关性。
Hepatology. 2012 Feb;55(2):429-36. doi: 10.1002/hep.24731. Epub 2011 Dec 22.
10
Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis.随机对照试验测试减肥对非酒精性脂肪性肝炎的影响。
Hepatology. 2010 Jan;51(1):121-9. doi: 10.1002/hep.23276.